Trial
NCT02607124
A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
Novartis
Condition
High Grade Glioma
Intervention
Ribociclib
Why stopped
A competing trial was opened for patient population with combination of ribociclib and everolimus.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-11-05